The Advocate

New test can detect plaques early in the disease: Alzheimer's Q&A

What is the Lumipulse test for Alzheimer’s disease? In May, the U.S. Food and Drug Administration permitted marketing of the Lumipulse (G B-Amyloid Ratio [1-42/1-40]) test to Fujirebio Diagnostics, ...

Expanded Insurance Coverage Validates Circle’s AI Approach to Coronary Plaque Evaluation

Highlights New permanent Category I CPT code 75577 for AI-enabled coronary plaque analysis took effect January 1, 2026Major payers, including ...
ConsumerAffairs

FDA clears first blood test for detecting Alzheimer’s plaques

The FDA has approved the first blood test to detect signs of Alzheimer’s disease, marking a major step toward easier diagnosis. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test identifies ...
Reuters

U.S. gives nod to Eli Lilly's brain plaque test

WASHINGTON (Reuters) - U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer's disease, the company said ...